Emerald Health Pharmaceuticals Inc. CONSULTING AGREEMENTConsulting Agreement • September 30th, 2022 • Emerald Health Pharmaceuticals Inc. • Pharmaceutical preparations • California
This Consulting Agreement ("Agreement") is made and entered into as of September 1, 2022, by and between Emerald Health Pharmaceuticals Inc. ("Company"), and Kranz & Associates Holdings, LLC, a Delaware limited liability company ("Consultant"). Company desires to retain Consultant as an independent contractor to perform consulting services for Company, and Consultant is willing to perform such services, on terms set forth more fully below. In consideration of the mutual promises contained herein, the parties agree as follows:
CONSULTING AGREEMENTConsulting Agreement • September 30th, 2022 • Emerald Health Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
WITNESSES THAT WHEREAS on July 8, 2022, the CEO and CFO of Emerald voluntarily resigned as they were in the process of negotiating a settlement with the Securities and Exchange Commission;
